相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants
Yeong Ok Baik et al.
VACCINE (2023)
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
Abdul Aziz Al-Fattah Yahaya et al.
VIRUSES-BASEL (2023)
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Moamen M. M. Elmassry et al.
MICROORGANISMS (2023)
The development of DNA vaccines against SARS-CoV-2
Kanwal Khalid et al.
ADVANCES IN MEDICAL SCIENCES (2023)
Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?
Wangxue Chen
EXPERT REVIEW OF VACCINES (2022)
Molecular Characterization and Designing of a Novel Multiepitope Vaccine Construct Against Pseudomonas aeruginosa
Jyotirmayee Dey et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2022)
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Matthew E. Oster et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2022)
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
Ganesh Kumar Rai et al.
LANCET INFECTIOUS DISEASES (2022)
Outer membrane vesicle vaccines for Neisseria gonorrhoeae
Evgeny A. Semchenko et al.
NATURE REVIEWS UROLOGY (2022)
The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus
Hamid Reza Jahantigh et al.
VACCINES (2022)
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Ashlan J. Kunz Coyne et al.
INFECTIOUS DISEASES AND THERAPY (2022)
Invasive Haemophilus influenza Type b in an Infant During the COVID-19 Pandemic: The Return of Diseases We Hoped Never to See Again ...
Christy Tabarani et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)
The clinical progress of mRNA vaccines and immunotherapies
Ann J. Barbier et al.
NATURE BIOTECHNOLOGY (2022)
Meningitis vaccine could protect against gonorrhoea, studies find
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2022)
Development of Klebsiella pneumoniae Capsule Polysaccharide-Conjugated Vaccine Candidates Using Phage Depolymerases
Tzu-Lung Lin et al.
FRONTIERS IN IMMUNOLOGY (2022)
Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates
Yixin Wu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Designing of a Novel Multi-Antigenic Epitope-Based Vaccine against E. hormaechei: An Intergraded Reverse Vaccinology and Immunoinformatics Approach
Thamer H. Albekairi et al.
VACCINES (2022)
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
Mark F. Cotton et al.
LANCET INFECTIOUS DISEASES (2022)
Modern vaccine development via reverse vaccinology to combat antimicrobial resistance
Asuka Joy Tobuse et al.
LIFE SCIENCES (2022)
120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Study
Joachim Doua et al.
Open Forum Infectious Diseases (2022)
Paratyphoid Fever A: Infection and Prevention
Lei Xie et al.
FRONTIERS IN MICROBIOLOGY (2022)
Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
Caixia Tan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Matthew Killough et al.
VACCINES (2022)
An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei
Fahad M. Alshabrmi et al.
VACCINES (2022)
Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice
Mohammad Omar Faruk Shaikh et al.
INFECTION AND IMMUNITY (2022)
Identification and construction of a multi-epitopes vaccine design against Klebsiella aerogenes: molecular modeling study
Sami I. Alzarea
SCIENTIFIC REPORTS (2022)
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis
Leonardo Martinez et al.
LANCET GLOBAL HEALTH (2022)
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial
Nginache Nampota-Nkomba et al.
Lancet Global Health (2022)
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
Amir Ghaemi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Immunogenicity and protective efficacy of the recombinant Pastureland multocida lipoproteins VacJ and PlpE, and outer membrane protein H from P. multocida A:1 in ducks
Yajuan Li et al.
FRONTIERS IN IMMUNOLOGY (2022)
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
Maryam Enayatkhani et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
Guy de Bruyn et al.
LANCET INFECTIOUS DISEASES (2021)
A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen
Gift Chiwala et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Genomic and Metabolic Characteristics of the Pathogenicity in Pseudomonas aeruginosa
Telma de Sousa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study
Gary R. Eldridge et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease
Ingrid L. Scully et al.
MICROORGANISMS (2021)
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Jeroen Pollet et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts
Jeremiah Chakaya et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
S. Moein Moghimi
MOLECULAR THERAPY (2021)
Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B
Annett Kleinschmidt et al.
NPJ VACCINES (2021)
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine
Priya Sellaturay et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian et al.
EXPERT REVIEW OF VACCINES (2021)
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Tanvir Mahtab Uddin et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates
Felix Behrens et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Engineering a Novel Bivalent Oral Vaccine against Enteric Fever
Annelise Soulier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa et al.
VACCINE (2021)
Development of Multi-epitope Subunit Vaccine Against Pseudomonas aeruginosa Using OprF/OprI and PopB Proteins
Fattaneh Sabzehali et al.
ARCHIVES OF CLINICAL INFECTIOUS DISEASES (2021)
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
Chih-Yun Lai et al.
VACCINE: X (2021)
Designing multi-epitope vaccine candidates against functional amyloids in Pseudomonas aeruginosa through immunoinformatic and structural bioinformatics approach
Ayesha Z. Beg et al.
INFECTION GENETICS AND EVOLUTION (2021)
Analysis of COVID-19 vaccines: Types, thoughts, and application
Xiucui Han et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Mucosal Immune Responses Against an Oral Enterotoxigenic Escherichia coli Vaccine Evaluated in Clinical Trials
Ann-Mari Svennerholm et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries
Mila Shakya et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG
Carlos Martin et al.
VACCINE (2021)
Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies
Jonah Clegg et al.
FRONTIERS IN IMMUNOLOGY (2021)
Klebsiella pneumoniae Lipopolysaccharides Serotype O2afg Induce Poor Inflammatory Immune Responses Ex Vivo
Matteo Bulati et al.
MICROORGANISMS (2021)
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years
Nicholas Kitchin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
Firdausi Qadri et al.
LANCET INFECTIOUS DISEASES (2020)
Yeast synthetic biology for designed cell factories producing secretory recombinant proteins
Eun Jung Thak et al.
FEMS YEAST RESEARCH (2020)
Prevention of tuberculosis in macaques after intravenous BCG immunization
Patricia A. Darrah et al.
NATURE (2020)
A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa
Maria P. Cabral et al.
PLOS PATHOGENS (2020)
Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of he current literature and plans for the future
J. Curtis Nickel et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection
Malihe Masomian et al.
VACCINES (2020)
Associations among Water, Sanitation, and Hygiene, and Food Exposures and Typhoid Fever in Case-Control Studies: A Systematic Review and Meta-Analysis
Sarah Brockett et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects
Scott M. Baliban et al.
CLINICAL INFECTIOUS DISEASES (2020)
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of InvasiveKlebsiella pneumoniaein a Multi-Country Collection
Myeongjin Choi et al.
FRONTIERS IN MICROBIOLOGY (2020)
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
Edison Ong et al.
FRONTIERS IN IMMUNOLOGY (2020)
Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets
Adam J. Schaenzer et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection
Marjory Xavier Rodrigues et al.
VACCINE (2020)
Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging
Kyung Oh Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
Design of Epitope-Based Peptide Vaccine against Pseudomonas aeruginosa Fructose Bisphosphate Aldolase Protein Using Immunoinformatics
Mustafa Elhag et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Antibiotics for cancer treatment: A double-edged sword
Yuan Gao et al.
JOURNAL OF CANCER (2020)
Design of Staphylococcus aureus New Vaccine Candidates with B and T Cell Epitope Mapping, Reverse Vaccinology, and Immunoinformatics
Mohamed A. Soltan et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2020)
Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial
Christopher Adlbrecht et al.
CRITICAL CARE (2020)
Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit
Aaron Kaviani et al.
CURRENT TRANSPLANTATION REPORTS (2020)
Antigenic: An improved prediction model of protective antigens
M. Saifur Rahman et al.
ARTIFICIAL INTELLIGENCE IN MEDICINE (2019)
A multiepitopic theoretical fusion construct based on in-silico epitope screening of known vaccine candidates for protection against wide range of enterobacterial pathogens
Ashutosh Kumar et al.
HUMAN IMMUNOLOGY (2019)
Status of vaccine research and development for Clostridium difficile
T. V. Riley et al.
VACCINE (2019)
Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902
Rezwanul Wahid et al.
CLINICAL IMMUNOLOGY (2019)
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study
Derick Wade et al.
TRIALS (2019)
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults
Megumi Inoue et al.
VACCINE (2019)
Progress towards the development of Klebsiella vaccines
Myeongjin Choi et al.
EXPERT REVIEW OF VACCINES (2019)
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
Vega Masignani et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
Subhra Chakraborty et al.
NPJ VACCINES (2019)
DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age
Pablo Obando-Pacheco et al.
EXPERT REVIEW OF VACCINES (2019)
Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
Irene Rivero-Calle et al.
INFECTION AND DRUG RESISTANCE (2019)
Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine
Hesam Dorosti et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Molecules that Inhibit Bacterial Resistance Enzymes
Yuan Liu et al.
MOLECULES (2019)
Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
Karin Dijkman et al.
NATURE MEDICINE (2019)
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Marjahan Akhtar et al.
VACCINE (2019)
Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies
Robert Booy et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
Nicola P. Klein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Genome-Based Approach Delivers Vaccine Candidates Against Pseudomonas aeruginosa
Irene Bianconi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antibody Specific B-Cell Epitope Predictions: Leveraging Information From Antibody-Antigen Protein Complexes
Martin Closter Jespersen et al.
FRONTIERS IN IMMUNOLOGY (2019)
BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
Harindra D. Sathkumara et al.
FRONTIERS IN IMMUNOLOGY (2019)
Global contributors to antibiotic resistance
Aastha Chokshi et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2019)
Cloning and expression of nlpA gene as DNA vaccine candidate against Acinetobacter baumannii
Rassoul Hashemzehi et al.
MOLECULAR BIOLOGY REPORTS (2018)
A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus
Miriam Moscoso et al.
VIRULENCE (2018)
The role of vaccines in fighting antimicrobial resistance (AMR)
Kathrin U. Jansen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
Nicolas Hegerle et al.
PLOS ONE (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune®
Bob Yang et al.
BJU INTERNATIONAL (2018)
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
Devyani Deshpande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
Andre G. Loxton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Future prospects for new vaccines against sexually transmitted infections
Sami L. Gottlieb et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Proof of principle for effectiveness of a gonorrhoea vaccine
Magnus Unemo et al.
NATURE REVIEWS UROLOGY (2017)
Simply put: Vaccination saves lives
Walter A. Orenstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy
Maria P. Cabral et al.
NATURE COMMUNICATIONS (2017)
Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi
Kun Xiong et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Pneumonia and Streptococcus pneumoniae vaccine
Gyu-Lee Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model
Hazel C. Dobinson et al.
CLINICAL INFECTIOUS DISEASES (2017)
Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field
Jan T. Poolman et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
Timo Vesikari et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2016)
Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development
Jennifer L. Edwards et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2016)
Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
Peter J. Dodd et al.
LANCET INFECTIOUS DISEASES (2016)
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
Michelle K. Paczosa et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation
Alexander Flood et al.
PLOS ONE (2016)
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
Nacho Aguilo et al.
TUBERCULOSIS (2016)
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
Nicole Bezay et al.
VACCINE (2016)
Pathogens Inactivated by Low-Energy-Electron Irradiation Maintain Antigenic Properties and Induce Protective Immune Responses
Jasmin Fertey et al.
VIRUSES-BASEL (2016)
An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii
Meng-Hooi Shu et al.
SCIENTIFIC REPORTS (2016)
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study
Laura L. Hammitt et al.
LANCET GLOBAL HEALTH (2016)
Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes
Murli Krishna et al.
FRONTIERS IN IMMUNOLOGY (2016)
Optimising Antibiotic Usage to Treat Bacterial Infections
Iona K. Paterson et al.
SCIENTIFIC REPORTS (2016)
Pneumococcal Capsules and Their Types: Past, Present, and Future
K. Aaron Geno et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Antibiotic Usage in First Time Coronary Artery Surgery
A Heaney et al.
Journal of Cardiothoracic Surgery (2015)
Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study
W. Abdullah Brooks et al.
VACCINE (2015)
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
Francois Spertini et al.
LANCET RESPIRATORY MEDICINE (2015)
Clinical vaccine development
Seunghoon Han
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Cholera Toxin Subunit B as Adjuvant-An Accelerator in Protective Immunity and a Break in Autoimmunity
Thomas Stratmann
VACCINES (2015)
Antibodies for Treatment of Clostridium difficile Infection
David P. Humphreys et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
The BCG replacement vaccine VPM1002: from drawing board to clinical trial
Stefan H. E. Kaufmann et al.
EXPERT REVIEW OF VACCINES (2014)
Multi-drug-resistant Staphylococcus aureus and future chemotherapy
K. Hiramatsu et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Recombinant protein expression in Escherichia coli: advances and challenges
German L. Rosano et al.
FRONTIERS IN MICROBIOLOGY (2014)
Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease
Lisa K. McNeil et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)
Effectiveness of Haemophilus influenzae Type b Vaccines Administered According to Various Schedules Systematic Review and Meta-analysis of Observational Data
Charlotte Jackson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity
Fan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
Leander Grode et al.
VACCINE (2013)
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Ainhoa Arbues et al.
VACCINE (2013)
Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm
Sara M. Soto
VIRULENCE (2013)
Protein carriers of conjugate vaccines Characteristics, development, and clinical trials
Michael E. Pichichero
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A Three-Dose Intramuscular Injection Schedule of Anthrax Vaccine Adsorbed Generates Sustained Humoral and Cellular Immune Responses to Protective Antigen and Provides Long-Term Protection against Inhalation Anthrax in Rhesus Macaques
Conrad P. Quinn et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Vaccines for enteric diseases: a meeting summary
Duncan Steele et al.
EXPERT REVIEW OF VACCINES (2012)
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
Davide Serruto et al.
VACCINE (2012)
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
Clint S. Schmidt et al.
VACCINE (2012)
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors
Annaliesa S. Anderson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells
Diane J. Ordway et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Aluminum Vaccine Adjuvants: Are they Safe?
L. Tomljenovic et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Haemophilus influenzae Infections in the H. influenzae Type b Conjugate Vaccine Era
Aarti Agrawal et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
A comprehensive study of the contribution of Salmonella enterica serovar Typhimurium SPI2 effectors to bacterial colonization, survival and replication in typhoid fever, macrophage and epithelial cell infection models
Michelle M. C. Buckner et al.
VIRULENCE (2011)
Global Trends in Typhoid and Paratyphoid Fever
John A. Crump et al.
CLINICAL INFECTIOUS DISEASES (2010)
Rationalizing the development of live attenuated virus vaccines
Adam S. Lauring et al.
NATURE BIOTECHNOLOGY (2010)
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
David Pace
EXPERT REVIEW OF VACCINES (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
Frank A. W. Verreck et al.
PLOS ONE (2009)
Engineering attenuated virus vaccines by controlling replication fidelity
Marco Vignuzzi et al.
NATURE MEDICINE (2008)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
BCG vaccination confers poor protection against M-tuberculosis HN878-induced central nervous system disease
Liana Tsenova et al.
VACCINE (2007)
The Neisseria meningitidis capsule is important for intracellular survival in human cells
Maria Rita Spinosa et al.
INFECTION AND IMMUNITY (2007)
Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine
S. F. Little et al.
VACCINE (2007)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Typhoid and paratyphoid fever in travellers
BA Connor et al.
LANCET INFECTIOUS DISEASES (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin
L Grode et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations
BD Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
MF Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)